MHRA announces measures to improve messaging on antidepressant risks

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced a series of measures to strengthen messaging around the key risks associated with antidepressant medicines. New boxed warnings will carry information on suicidal thoughts and behaviours, and signpost where patients can get help. And new patient cards will be available in digital or hard copy...Read moreThe post MHRA announces measures to improve messaging on antidepressant risks appeared first on Nursing in Practice.